Deciphering the circRNA-Mediated ceRNA regulatory network in dendritic cells during H37Ra and BCG infection

解析H37Ra和BCG感染期间树突状细胞中circRNA介导的ceRNA调控网络

阅读:1

Abstract

BACKGROUND: Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculosis (M.tb), and poses a significant threat to global human health. Dendritic cells (DCs) represent the most potent antigen-presenting cells and play a critical role in host defenses against M.tb infection. METHODS: We analyzed GEO datasets to identify differentially expressed circRNAs and mRNAs in M.tb-infected DCs. The downstream miRNAs were predicted using the circBank and CircInteractome databases, while the target mRNAs were predicted using TargetScan and miRanda. A ceRNA regulatory network consisting of 10 circRNAs, 41 miRNAs, and 145 mRNAs was constructed. Protein-protein interaction (PPI) analysis identified 30 hub nodes, which were further subjected to Gene Ontology and KEGG enrichment analyses.Subsequently, the circRNA/miRNA/mRNA regulatory axis was assessed, followed by validation using qRT-PCR and evaluation through ROC curve analysis. RESULTS: Four core genes-STAT1, BCL2, TRAF6, and IL1A-were enriched in tuberculosis,JAK-STAT,and NF-κB pathways. Two ceRNA axes, circNFATC3/miR-150-5p/STAT1 and circNFATC3/miR-23a-3p/BCL2, were validated by qRT-PCR, showing expression patterns consistent with high-throughput data. ROC analysis demonstrated strong diagnostic potential (AUC >0.7) for both axes. CONCLUSION: This study constructed a ceRNA regulatory network in M.tb-infected DCs, identified key molecular modules, and proposed circRNA-associated axes as promising biomarkers for early TB diagnosis and potential therapeutic targets.However, these findings are limited to experimental models of DCs infection and require further validation in clinical samples and in vivo models.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。